Portage biotech reports results for fiscal quarter ended june 30, 2023 and business update

Company focused on accelerating clinical programs for port-2, port-6, and port-7 company focused on accelerating clinical programs for port-2, port-6, and port-7
ATON Ratings Summary
ATON Quant Ranking